FGFR3 and urinary bladder carcinoma: Other researchers have demonstrated that a single-chain anti-FGFR3 Fv fragment fused to a toxin gene product, rGel, had the ability to inhibit the growth of a xenograft bladder cancer cell line (Martinez-Torrecuadrada et al., 2008).